Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the U.S. Food and Drug Administration…
On May 18, 2020, Moderna announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus…
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…
On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…
On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…
On May 8, 2020, Abbott announced new research, published in the Journal of Clinical Microbiology, which found that…
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
On Apr. 30, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
On Apr. 30, 2020, InBios announced that it had been awarded a contract from the Biomedical Advanced Research…
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that they…
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
On Apr. 27, 2020, BioAegis Therapeutics announced it had published gene expression data in animal studies where recombinant…
On Apr. 24, 2020, the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication regarding known…
On Apr. 24, 2020, BioSig Technologies announced that subsidiary ViralClear had submitted an Investigational New Drug (IND) application…